JP2008504850A5 - - Google Patents

Download PDF

Info

Publication number
JP2008504850A5
JP2008504850A5 JP2007516728A JP2007516728A JP2008504850A5 JP 2008504850 A5 JP2008504850 A5 JP 2008504850A5 JP 2007516728 A JP2007516728 A JP 2007516728A JP 2007516728 A JP2007516728 A JP 2007516728A JP 2008504850 A5 JP2008504850 A5 JP 2008504850A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
nos
morphogenetic protein
sequences shown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007516728A
Other languages
English (en)
Other versions
JP2008504850A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/021270 external-priority patent/WO2006098744A2/en
Publication of JP2008504850A publication Critical patent/JP2008504850A/ja
Publication of JP2008504850A5 publication Critical patent/JP2008504850A5/ja
Pending legal-status Critical Current

Links

Claims (11)

  1. 骨形成タンパク質に結合するポリペプチドである結合モジュールであって、該ポリペプチドは:
    (i)配列番号11〜26、44〜55、57〜72、74、および77〜93で示される配列のうちのいずれか一つに少なくとも70%同一である配列;
    (ii)配列番号11〜26、44〜72、74、および77〜93で示される配列のうちのいずれか一つに少なくとも75%同一である配列;
    (iii)配列番号11〜26、44〜72、74、および77〜93で示される配列のうちのいずれか一つに少なくとも80%同一である配列;
    (iv)配列番号11〜26、44〜72、74、および77〜93で示される配列のうちのいずれか一つに少なくとも88%同一である配列;
    (v)配列番号11〜26、44〜72、74、および77〜93で示される配列のうちのいずれか一つに少なくとも95%同一である配列;または
    (vi)配列番号11〜26、44〜72、74、および77〜93で示される配列のうちのいずれか
    を含む、結合モジュール。
  2. 前記骨形成タンパク質が骨形成タンパク質−2である、請求項1に記載の結合モジュール。
  3. 骨形成タンパク質−2に結合するポリペプチドである結合モジュールであって、該ポリペプチドは、配列番号11〜24、44〜55、57〜72および74で示される配列のうちのいずれか一つと、1〜8個のアミノ酸が異なる配列を含む、結合モジュール。
  4. 前記ポリペプチドは、配列番号11〜24、44〜55、57〜72および74で示される配列のうちのいずれか一つと、1〜7個のアミノ酸が異なる、請求項3に記載の結合モジュール。
  5. 前記ポリペプチドは、配列番号11〜24、44〜55、57〜72および74で示される配列のうちのいずれか一つと、1〜6個のアミノ酸が異なる、請求項3に記載の結合モジュール。
  6. 前記ポリペプチドは、配列番号11〜24、44〜55、57〜72および74で示される配列のうちのいずれか一つと、1〜5個のアミノ酸が異なる、請求項3に記載の結合モジュール。
  7. 骨形成タンパク質−2に結合するポリペプチドである結合モジュールであって、該ポリペプチドは配列番号28および94で示される配列のうちのいずれか一つを含み、該ポリペプチドは40個までのアミノ酸を含む、結合モジュール。
  8. 請求項1〜7のいずれか一項で定義されるポリペプチドをコードするヌクレオチド配列を含む、単離された核酸。
  9. 骨形成を促進するための組成物であって、骨形成タンパク質−2(BMP−2)結合ポリペプチドを含み、該BMP−2結合ポリペプチドは、配列番号27、28、73、および94で示される配列のうちのいずれか一つを含み、該ポリペプチドは、BMP−2を結合し、かつBMP−2を提示して、骨形成を促進する、組成物。
  10. インプラントの骨同化を促進し、治癒を促進し、および/またはインプラントの部位における炎症を低減するための組成物であって、該組成物は、骨同化を促進し、治癒を促進し、および/または炎症を低減するために、骨形成タンパク質−2(BPM−2)に結合して、該BMP−2を提示するポリペプチドを含み、該ポリペプチドは、配列番号27、28、73、および94で示される配列のうちのいずれか一つを含む、組成物。
  11. 骨形成タンパク質を結合するためのインビトロの方法であって、該方法は、該骨形成タンパク質に結合するポリペプチドを使用する工程を含み、該ポリペプチドは、配列番号27、28、73、および94で示される配列のうちのいずれか一つを含む、方法。
JP2007516728A 2004-06-16 2005-06-15 整形外科インプラントの表面に対する標的分析物の特異的接着を促進するためのifbm Pending JP2008504850A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US58001904P 2004-06-16 2004-06-16
US65133805P 2005-02-09 2005-02-09
US65174705P 2005-02-10 2005-02-10
PCT/US2005/021270 WO2006098744A2 (en) 2004-06-16 2005-06-15 Ifbm’s to promote attachment of target analytes

Publications (2)

Publication Number Publication Date
JP2008504850A JP2008504850A (ja) 2008-02-21
JP2008504850A5 true JP2008504850A5 (ja) 2011-05-26

Family

ID=35784316

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007516728A Pending JP2008504850A (ja) 2004-06-16 2005-06-15 整形外科インプラントの表面に対する標的分析物の特異的接着を促進するためのifbm

Country Status (8)

Country Link
US (15) US20060051396A1 (ja)
EP (4) EP1793875B9 (ja)
JP (1) JP2008504850A (ja)
AT (1) ATE462451T1 (ja)
CA (1) CA2569864A1 (ja)
DE (1) DE602005020320D1 (ja)
ES (1) ES2342551T3 (ja)
WO (2) WO2006098744A2 (ja)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7883720B2 (en) * 2003-07-09 2011-02-08 Wisconsin Alumni Research Foundation Charge-dynamic polymers and delivery of anionic compounds
JP4885542B2 (ja) * 2003-07-30 2012-02-29 独立行政法人科学技術振興機構 チタン、銀、シリコンに結合能を有するペプチド
JP2008504850A (ja) 2004-06-16 2008-02-21 アフィナジー, インコーポレイテッド 整形外科インプラントの表面に対する標的分析物の特異的接着を促進するためのifbm
US20070099245A1 (en) * 2005-09-29 2007-05-03 Boris Gorovits Assays for neutralizing antibodies
US7807624B2 (en) * 2006-01-11 2010-10-05 Affinergy, Inc. Methods and compositions for promoting attachment of cells of endothelial cell lineage to medical devices
US20080015138A1 (en) * 2006-07-17 2008-01-17 Affinergy, Inc. Metal binding compounds, metal binding compositions, and their uses
EP2089072B1 (en) * 2006-09-06 2014-06-04 Boston Scientific Limited Medical devices having a coating for promoting endothelial cell adhesion
US8834918B2 (en) * 2007-01-22 2014-09-16 Wisconsin Alumni Research Foundation Modified multilayered film
CA2678205A1 (en) * 2007-02-13 2008-08-21 Paul H. Nye A personal affector machine
US20090018642A1 (en) * 2007-03-15 2009-01-15 Boston Scientific Scimed, Inc. Methods to improve the stability of celluar adhesive proteins and peptides
US7977313B2 (en) * 2007-04-27 2011-07-12 Affinergy, Inc. Methods and compositions for promoting localization of pharmaceutically active agents to bone
JP5642540B2 (ja) * 2007-06-01 2014-12-17 アロウ・インターナショナル・インコーポレイテッドArrow International, Inc. 組み合わされた線維素溶解性および抗菌性のカテーテル、およびその使用
JP2009051773A (ja) * 2007-08-27 2009-03-12 Toyobo Co Ltd 細胞接着能を有するhsp70ファミリータンパク質
EP2182888A4 (en) * 2007-09-04 2010-09-08 Affinergy Inc METHODS AND COMPOSITIONS FOR THE ADMINISTRATION OF GROWTH FACTOR TO A FIBROUS CONJUNCTIVE TISSUE
WO2009049092A1 (en) * 2007-10-09 2009-04-16 Wisconsin Alumni Research Foundation Covalent assembly of ultrathin polymeric films
US20090105375A1 (en) * 2007-10-09 2009-04-23 Lynn David M Ultrathin Multilayered Films for Controlled Release of Anionic Reagents
WO2009054967A2 (en) * 2007-10-22 2009-04-30 Synthes (U.S.A.) Compositions for delivery of glycopeptide antibiotics
WO2009055313A1 (en) * 2007-10-22 2009-04-30 Affinergy Inc. Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces
US8637455B2 (en) 2007-10-22 2014-01-28 Affinergy, Llc Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces
US20090246249A1 (en) * 2008-03-27 2009-10-01 Affinergy Coating compositions having improved performance
US8324333B2 (en) 2008-06-05 2012-12-04 Wisconsin Alumni Research Foundation Anionic charge-dynamic polymers for release of cationic agents
CA2769878A1 (en) 2008-08-07 2010-02-11 Bioactive Surgical, Inc. Stem cell capture and immobilization coatings for medical devices and implants
US7700923B2 (en) * 2008-09-20 2010-04-20 Varian Medical Systems, Inc. Apparatus of photoconductor crystal growth
CN104892728A (zh) 2008-09-24 2015-09-09 特尔哈肖梅尔医学研究基础设施和服务有限公司 用于防止细胞粘附的肽和组合物及其使用方法
US20100098737A1 (en) * 2008-10-17 2010-04-22 Affinergy, Inc. methods and compositions for delivery of glycopeptide antibiotics to medical device surfaces
EP2387376A4 (en) * 2009-01-19 2014-04-23 Cochlear Ltd SURFACE CHANGE FOR IMPLANTABLE MEDICAL DEVICE
EP2389195B1 (en) 2009-01-20 2015-05-20 Homayoun H. Zadeh Antibody mediated osseous regeneration
US8545459B2 (en) * 2009-02-25 2013-10-01 Teleflex Medical Incorporated Stabilized enzyme compositions
US9333280B2 (en) 2009-02-25 2016-05-10 Teleflex Medical Incorporated Stabilized enzyme compositions
US8574612B2 (en) * 2009-03-04 2013-11-05 Boston Scientific Scimed, Inc. Medical devices having a coating of biologic macromolecules
US20100249783A1 (en) * 2009-03-24 2010-09-30 Warsaw Orthopedic, Inc. Drug-eluting implant cover
US9414864B2 (en) 2009-04-15 2016-08-16 Warsaw Orthopedic, Inc. Anterior spinal plate with preformed drug-eluting device affixed thereto
US9078712B2 (en) * 2009-04-15 2015-07-14 Warsaw Orthopedic, Inc. Preformed drug-eluting device to be affixed to an anterior spinal plate
US8079737B2 (en) * 2009-04-20 2011-12-20 Harvatek Corporation Reflection-type light-emitting module with high heat-dissipating and high light-generating efficiency
WO2011060076A1 (en) * 2009-11-10 2011-05-19 Amgen Inc. Anti-c-mpl antibodies
WO2011063128A1 (en) * 2009-11-18 2011-05-26 Affinergy, Inc. Implantable bone graft materials
CA2792611A1 (en) * 2010-03-16 2011-09-22 Advanced Technologies And Regenerative Medicine, Llc Affinity peptides toward bmp-2
US8707950B1 (en) * 2010-08-04 2014-04-29 Darren Rubin Universal medical gas delivery system
US11628267B2 (en) 2010-08-04 2023-04-18 Medline Industries, Lp Universal medical gas delivery system
US9186243B2 (en) * 2011-05-31 2015-11-17 Novartis Ag Accommodative intraocular lens and method of implantation
US9586381B1 (en) 2013-10-25 2017-03-07 Steriplate, LLC Metal plated object with biocidal properties
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
WO2016176146A1 (en) * 2015-04-26 2016-11-03 The Trustees Of Princeton University Surfaces comprising attached quorum sensing modulators
US9999899B2 (en) 2016-11-01 2018-06-19 International Business Machines Corporation Controlled exposure of in-vivo sensors
EP3796941A4 (en) * 2018-05-30 2022-12-28 Purdue Research Foundation TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR
US20210238236A1 (en) * 2018-06-20 2021-08-05 Dwi-Leibniz-Institut Für Interaktive Materialien E.V. Fusion peptides or proteins, their use, and systems and kits based thereupon, for the separation and/or detection of plastics, particularly of microplastics
EP3864025B1 (en) 2018-10-12 2024-05-08 Theradaptive, Inc. Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof
WO2020208418A1 (en) * 2019-04-12 2020-10-15 Azura Ophthalmics Ltd. Compositions and methods for the treatment of contact lens discomfort
US20210154403A1 (en) * 2019-11-25 2021-05-27 Thomas Leroy Schmitz Joint capsule fluid delivery
CN115279458A (zh) 2020-01-10 2022-11-01 阿祖拉眼科有限公司 组合物和敏感性说明
WO2021222321A1 (en) * 2020-04-27 2021-11-04 Board Of Trustees Of The University Of Arkansas Cellulose based anti-viral anti-microbial spray coating
US11141528B1 (en) 2020-12-14 2021-10-12 Thomas Leroy Schmitz Therapeutic fluid delivery cartridge

Family Cites Families (118)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA92121A (en) 1904-11-07 1905-03-14 William Waid Paddock Pressure filter
US4244946A (en) 1979-06-11 1981-01-13 The Salk Institute For Biological Studies Water-soluble peptides affecting gonadal function
FR2501680A1 (fr) 1981-03-12 1982-09-17 Elf Aquitaine Synthese de tetra mercaptides stanniques
US4472840A (en) 1981-09-21 1984-09-25 Jefferies Steven R Method of inducing osseous formation by implanting bone graft material
US4442133A (en) * 1982-02-22 1984-04-10 Greco Ralph S Antibiotic bonding of vascular prostheses and other implants
US5217492A (en) 1982-09-29 1993-06-08 Bio-Metric Systems, Inc. Biomolecule attachment to hydrophobic surfaces
US4526909A (en) 1984-01-09 1985-07-02 Regents Of The University Of California Polymethylmethacrylate delivery system for bone morphogenetic protein
US4563489A (en) 1984-02-10 1986-01-07 University Of California Biodegradable organic polymer delivery system for bone morphogenetic protein
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
US5079342A (en) * 1986-01-22 1992-01-07 Institut Pasteur Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
US5543394A (en) 1986-07-01 1996-08-06 Genetics Institute, Inc. Bone morphogenetic protein 5(BMP-5) compositions
US5013649A (en) 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
US5606019A (en) 1987-10-29 1997-02-25 Protien Polymer Technologies, Inc. Synthetic protein as implantables
GB2215209B (en) 1988-03-14 1992-08-26 Osmed Inc Method and apparatus for biodegradable, osteogenic, bone graft substitute device
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US5344654A (en) 1988-04-08 1994-09-06 Stryker Corporation Prosthetic devices having enhanced osteogenic properties
US5019393A (en) 1988-08-03 1991-05-28 New England Deaconess Hospital Corporation Biocompatible substance with thromboresistance
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US6261271B1 (en) 1989-01-18 2001-07-17 Becton Dickinson And Company Anti-infective and antithrombogenic medical articles and method for their preparation
US5356630A (en) 1989-02-22 1994-10-18 Massachusetts Institute Of Technology Delivery system for controlled release of bioactive factors
JPH0327172A (ja) 1989-06-19 1991-02-05 Nissan Chem Ind Ltd 布の漂白方法
US5635482A (en) 1989-08-14 1997-06-03 The Regents Of The University Of California Synthetic compounds and compositions with enhanced cell binding
US5236456A (en) 1989-11-09 1993-08-17 Osteotech, Inc. Osteogenic composition and implant containing same
US5780225A (en) 1990-01-12 1998-07-14 Stratagene Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
US5314995A (en) 1990-01-22 1994-05-24 Oncogen Therapeutic interleukin-2-antibody based fusion proteins
DE4002897A1 (de) 1990-02-01 1991-08-08 Behringwerke Ag Herstellung und verwendung von genbanken synthetischer menschlicher antikoerper ("synthetische human-antikoerper-bibliotheken")
US5747334A (en) 1990-02-15 1998-05-05 The University Of North Carolina At Chapel Hill Random peptide library
US5498538A (en) 1990-02-15 1996-03-12 The University Of North Carolina At Chapel Hill Totally synthetic affinity reagents
AP237A (en) 1990-05-29 1993-04-29 Cedars Sinai Medical Center Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use.
US5645591A (en) 1990-05-29 1997-07-08 Stryker Corporation Synthetic bone matrix
US5264563A (en) 1990-08-24 1993-11-23 Ixsys Inc. Process for synthesizing oligonucleotides with random codons
US5520664A (en) 1991-03-01 1996-05-28 Spire Corporation Catheter having a long-lasting antimicrobial surface treatment
US5652118A (en) 1991-03-11 1997-07-29 Creative Biomolecules, Inc. Nucleic acid encoding a novel morphogenic protein, OP-3
ATE142460T1 (de) 1991-06-21 1996-09-15 Genetics Inst Osteogene proteine enthaltende arzneimittel
US5667988A (en) 1992-01-27 1997-09-16 The Scripps Research Institute Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
US5217493A (en) * 1992-03-11 1993-06-08 Board Of Regents, The University Of Texas System Antibacterial coated medical implants
US5681575A (en) 1992-05-19 1997-10-28 Westaim Technologies Inc. Anti-microbial coating for medical devices
JP3312357B2 (ja) 1992-12-11 2002-08-05 ザ ダウ ケミカル カンパニー 多価の一本鎖抗体
US5847047A (en) * 1993-06-22 1998-12-08 E. I. Du Pont De Nemours And Company Antimicrobial composition of a polymer and a peptide forming amphiphilic helices of the magainin-type
US6361526B1 (en) 1993-11-01 2002-03-26 Medtronic Xomed, Inc. Antimicrobial tympanostomy tube
DK0754756T3 (da) * 1994-03-04 2006-03-13 Ajinomoto Kk Fremgangsmåde til fremstilling af L-lysin
US5824483A (en) 1994-05-18 1998-10-20 Pence Inc. Conformationally-restricted combinatiorial library composition and method
JPH07313169A (ja) * 1994-05-26 1995-12-05 Nippon Ham Kk 骨形成因子受容体改変体の遺伝子
EP0789783B1 (en) 1994-09-21 2002-05-08 Cytogen Corporation Antigen binding peptides (abtides) from peptide libraries
US6746482B2 (en) * 1994-10-17 2004-06-08 Baxter International Inc. Method for producing medical devices and devices so produced
WO1996013583A2 (en) 1994-10-20 1996-05-09 Morphosys Gesellschaft Für Proteinoptimierung Mbh Targeted hetero-association of recombinant proteins to multi-functional complexes
DE4441124C2 (de) 1994-11-18 1997-03-27 Heraeus Kulzer Gmbh Verfahren zur Erzeugung eines haftfesten, feuchtigkeitsdichten Überzugs aus Kunststoff auf einer Unterlage und dessen Verwendung
US6071890A (en) 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
AUPN024994A0 (en) * 1994-12-23 1995-01-27 Ludwig Institute For Cancer Research Assay and peptides for use therein
US5817748A (en) * 1995-03-17 1998-10-06 The Research Foundation Of State University Of New York Mimotopes of human Platelet glycoprotein Ib/IX
US5624704A (en) 1995-04-24 1997-04-29 Baylor College Of Medicine Antimicrobial impregnated catheters and other medical implants and method for impregnating catheters and other medical implants with an antimicrobial agent
US5702892A (en) 1995-05-09 1997-12-30 The United States Of America As Represented By The Department Of Health And Human Services Phage-display of immunoglobulin heavy chain libraries
US5622699A (en) 1995-09-11 1997-04-22 La Jolla Cancer Research Foundation Method of identifying molecules that home to a selected organ in vivo
US5709672A (en) 1995-11-01 1998-01-20 Texas Tech University Health Sciences Center Silastic and polymer-based catheters with improved antimicrobial/antifungal properties
IE80466B1 (en) 1995-11-10 1998-07-29 Elan Corp Plc Peptides which enhance transport across tissues and methods of identifying and using the same
FR2741892B1 (fr) 1995-12-04 1998-02-13 Pasteur Merieux Serums Vacc Procede de preparation d'une banque multicombinatoire de vecteurs d'expression de genes d'anticorps, banque et systemes d'expression d'anticorps "coliclonaux" obtenus
US6031071A (en) 1996-01-24 2000-02-29 Biophage, Inc. Methods of generating novel peptides
EP0800901B1 (de) 1996-04-10 2003-07-02 Dieffenbacher Schenck Panel GmbH Verfahren zur Herstellung eines Vlieses und Vorrichtung
ATE282706T1 (de) * 1996-09-04 2004-12-15 Syngenta Mogen Bv Gegen pilze gerichtete proteine, dafuer kodierende dna und wirtsorganismen, die diese beinhalten
US6617114B1 (en) * 1996-10-31 2003-09-09 Karo Bio Ab Identification of drug complementary combinatorial libraries
US5756332A (en) * 1996-12-26 1998-05-26 Incyte Pharmaceuticals, Inc. Guanosine monophosphate reductase
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
ATE277645T1 (de) 1997-05-22 2004-10-15 Biomet Deutschland Gmbh Peptid-beschichtete implantate und verfahren zu ihrer herstellung
JP2002504361A (ja) * 1998-02-26 2002-02-12 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド 36個のヒト分泌タンパク質
US6281331B1 (en) 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
US6121236A (en) 1998-03-24 2000-09-19 The Children's Medical Center Corporation Multivalent ligands which modulate angiogenesis
US7208011B2 (en) 2001-08-20 2007-04-24 Conor Medsystems, Inc. Implantable medical device with drug filled holes
US6428579B1 (en) * 1998-07-01 2002-08-06 Brown University Research Foundation Implantable prosthetic devices coated with bioactive molecules
US6780582B1 (en) 1998-07-14 2004-08-24 Zyomyx, Inc. Arrays of protein-capture agents and methods of use thereof
WO2000004941A1 (en) * 1998-07-24 2000-02-03 Pharmacal Biotechnologies, Inc. Osseous tissue reconstruction system and method
US20030236190A1 (en) * 1998-09-02 2003-12-25 Renuka Pillutla Isulin and IGF-1 receptor agonists and antagonists
US7176275B2 (en) * 1998-09-04 2007-02-13 Samuel Bogoch Anthrax and small pox replikins and methods of use
AU1742000A (en) * 1998-11-20 2000-06-13 Vincent Guerriero Dna encoding proteins that inhibit hsp70 function
US7090973B1 (en) * 1999-04-09 2006-08-15 Oscient Pharmaceuticals Corporation Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
CA2371011C (en) * 1999-04-28 2009-12-22 Eidgenossisch Technische Hochschule Zurich Polyionic coatings in analytic and sensor devices
US6544768B1 (en) * 1999-05-11 2003-04-08 Cornell Research Foundation, Inc. Mammalian soluble adenylyl cyclase
EP1203016A2 (en) * 1999-08-09 2002-05-08 Incyte Genomics, Inc. Proteases and protease inhibitors
US7304127B2 (en) * 1999-08-27 2007-12-04 United States Of America As Represented By The Secretary, Department Of Health And Human Services Polypeptides that bind HIV gp120 and related nucleic acids, antibodies, compositions, and methods of use
JP2003511012A (ja) * 1999-09-24 2003-03-25 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド 32個のヒト分泌タンパク質
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
WO2001056627A1 (en) * 2000-01-12 2001-08-09 Am-Pharma B.V. Medical device coated with antimicrobial peptides
AU2001245734A1 (en) 2000-03-15 2001-09-24 Orbus Medical Technologies Inc. Coating that promotes endothelial cell adherence
US20030229393A1 (en) 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
AU2001253852A1 (en) * 2000-03-31 2001-10-15 Institut Gustave Roussy Preprocalcitonin as tumor rejection antigen precursor and uses thereof
EP1142596A1 (en) * 2000-04-03 2001-10-10 Universiteit Gent Compositions of crosslinkable prepolymers for use in therapeutically active biodegradable implants
US20110131679A2 (en) * 2000-04-19 2011-06-02 Thomas La Rosa Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
US6716811B1 (en) * 2000-07-20 2004-04-06 Affymax, Inc. Compounds having affinity for the granulocyte-colony stimulating factor receptor (G-CSFR) and associated uses
US6727223B2 (en) * 2000-08-04 2004-04-27 Urex Biotech, Inc. Treatment of microbial infections with bacterial proteins and peptides
DE10040105A1 (de) * 2000-08-17 2002-02-28 Merck Patent Gmbh Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften
US6962799B2 (en) * 2000-08-21 2005-11-08 Incyte Corporation Microtubule-associated proteins and tubulins
CA2424730A1 (en) * 2000-10-02 2002-04-11 Arizeke Pharmaceuticals, Inc. Compositions and methods for the transport of biologically active agents across cellular barriers
WO2002088375A2 (en) * 2000-10-27 2002-11-07 Diadexus, Inc. Compositions and methods relating to breast specific genes and proteins
US20030003440A1 (en) * 2001-03-14 2003-01-02 Lucia Lopalco Novel CCR5 epitope and antibodies against it
CA2449573A1 (en) 2001-06-08 2002-12-19 Smith & Nephew Plc Bmp binding proteins for use in bone or cartilage regeneration
JP2005502335A (ja) * 2001-08-08 2005-01-27 インサイト・ゲノミックス・インコーポレイテッド 細胞成長、分化および細胞死関連タンパク質
EP1419173B1 (en) 2001-08-10 2008-11-26 Novartis AG Peptides that bind to atherosclerotic lesions
JP4933708B2 (ja) 2001-08-31 2012-05-16 善彦 西村 骨形成作用を有する新規なペプチドおよびこれを固定化してなる骨形成促進剤
US6596338B2 (en) 2001-10-24 2003-07-22 Howmedica Osteonics Corp. Antibiotic calcium phosphate coating
DE60232688D1 (de) * 2001-11-20 2009-07-30 Univ Duke Grenzflächen-biomaterialien
US7381426B2 (en) 2002-01-24 2008-06-03 Southwest Research Institute Targeted delivery of bioactive factors to the systemic skeleton
US7355022B2 (en) * 2002-02-12 2008-04-08 Licentia Ltd. Gene functionally related to dyslexia
US7314974B2 (en) * 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties
US7323542B2 (en) 2002-02-21 2008-01-29 University Of Virginia Patent Foundation Bone targeting peptides
EP2339347A1 (en) * 2002-04-12 2011-06-29 O'Dowd, Brian, F. Method of identifying transmembrane protein-interacting compounds
BR0309877A (pt) * 2002-05-03 2005-04-26 Millenium Biologix Inc Peptìdeos estimuladores de tecido conectivo
EP1549672B1 (en) * 2002-05-03 2010-09-01 Mayo Foundation For Medical Education And Research Ablated slam-dependent cell entry
US7449480B2 (en) * 2002-05-14 2008-11-11 Baylor College Of Medicine Small molecule inhibitors of HER2 expression
JP2005185101A (ja) 2002-05-30 2005-07-14 National Institute Of Agrobiological Sciences 植物の全長cDNAおよびその利用
US7166574B2 (en) * 2002-08-20 2007-01-23 Biosurface Engineering Technologies, Inc. Synthetic heparin-binding growth factor analogs
US7598344B2 (en) 2002-09-04 2009-10-06 Board Of Regents, The University Of Texas System Composition, method and use of bi-functional biomaterials
US7238669B2 (en) 2002-09-11 2007-07-03 The Curators Of The University Of Missouri Phage-display peptides as novel antimicrobial agents against Haemophilus influenzae
US7282214B2 (en) 2002-12-19 2007-10-16 Johnson & Johnson Vision Care, Inc. Biomedical devices with antimicrobial coatings
US7163920B2 (en) 2003-09-30 2007-01-16 Ethicon, Inc. Peptide with osteogenic activity
WO2005072403A2 (en) * 2004-01-28 2005-08-11 The Regents Of The University Of California Bone morphogenic protein binding peptide
US7528105B1 (en) * 2004-02-10 2009-05-05 Biosurface Engineering Technologies Heterodimeric chain synthetic heparin-binding growth factor analogs
KR101013999B1 (ko) * 2004-03-19 2011-02-14 재단법인서울대학교산학협력재단 표면에 골조직 형성 증진 펩타이드가 고정된 차폐막 및임플란트
JP2008504850A (ja) 2004-06-16 2008-02-21 アフィナジー, インコーポレイテッド 整形外科インプラントの表面に対する標的分析物の特異的接着を促進するためのifbm
US7807624B2 (en) 2006-01-11 2010-10-05 Affinergy, Inc. Methods and compositions for promoting attachment of cells of endothelial cell lineage to medical devices

Similar Documents

Publication Publication Date Title
JP2008504850A5 (ja)
JP3231045B2 (ja) 固体支持体上でのポリピロール及びポリイミダゾールカルボキサミドの合成方法
JP3753939B2 (ja) Dnaの特定塩基配列をアルキル化する化合物及びその合成法
JP2008505985A5 (ja)
Sluka et al. Importance of minor-groove contacts for the recognition of DNA by the binding domain of Hin recombinase
WO2006018967A1 (ja) TGF-β遺伝子発現抑制剤
TW201215408A (en) Antisense nucleic acid
AU7406700A (en) Design of high affinity rnase h recruiting oligonucleotide
JP2008517605A5 (ja)
MX2009000656A (es) Acidos nucleicos que se fijan a sdf-i.
EP2438962A3 (en) Polynucleotides and polypeptide sequences involved in the process of bone remodeling
JP6057185B2 (ja) 核酸リンカー
US20030152984A1 (en) Method for the manufacture of DNA
Huang et al. The α-helical peptide nucleic acid concept: Merger of peptide secondary structure and codified nucleic acid recognition
JP2001500387A (ja) ペプチド核酸のモノマー及びオリゴマー
EP2275547A3 (en) Polynucleotides and polypeptide sequences involved in the process of bonne remodeling
US20230340496A1 (en) Aptamer template and method for preparing aptamer by using same
He et al. Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry
WO2003062417A1 (fr) Produit de ligation arn-adn, et utilisation correspondante
JP2002291491A (ja) Rna−dna結合体
JP2023531249A (ja) Fubp1発現を調節するための増強されたオリゴヌクレオチド
JP2003334089A5 (ja)
US11865181B2 (en) Peptidic materials that traffic efficiently to the cell cytosol and nucleus
JPWO2017047741A1 (ja) 筋萎縮症治療用アンチセンス核酸
US20230053360A1 (en) Nucleic acid-peptide-nucleic acid conjugate molecules and methods of making the same